Interpreting new treatment guidelines for non-ST-segment elevation acute coronary syndromes

American Journal of Cardiology

Volumn 88, Issue 8 SUPPL. 1, 2001, Pages 19-24

  Boden, William E ^a,b  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBIN; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; CREATINE KINASE MB; DALTEPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; LEPIRUDIN; TIROFIBAN; TISSUE PLASMINOGEN ACTIVATOR; TROPONIN;

ANTICOAGULANT THERAPY; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DISEASE MARKER; ELECTROCARDIOGRAPHY MONITORING; EVALUATION; HEALTH CARE COST; HEART CATHETERIZATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HIGH RISK POPULATION; HOSPITAL CARE; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; Q WAVE; REVIEW; SOLDIER; ST SEGMENT ELEVATION; STRESS; TREATMENT INDICATION; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 0035909211     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)02038-0     Document Type: Article

References (18)

1. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina)
2. Unstable angina: An etiologic approach to management
3. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial
4. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy
5. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina
6. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction
7. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
8. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Randomized Efficacy study of tirofiban for outcomes and restenosis
9. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease
10. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 11B Trial
11. Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study
12. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revas-cularisation procedures in patients with acute myocardial ischaemia without ST elevation: A randomised trial
13. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
14. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
15. Invasive compared with non-invasive treatment in unstable coronary-artery disease. FRISC II prospective randomised multicentre study
16. An early invasive treatment strategy reduces cardiac events regardless of troponin levels in unstable coronary artery (UCAD) with and without troponin-elevation: A FRISC II substudy
17. ST depression in ECG at entry identifies patients who may benefit most from early revascularisation in unstable coronary artery disease: A FRISC II substudy
18. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban